Drug-reponse_Curated
| Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
|---|---|---|---|---|---|---|---|
| Paclitaxel | hsa-miR-30b-5p | miRNA | resistant | High | Breast Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | sensitive | High | Breast Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | High | Ehrlich Ascites Tumor | Homo sapiens | |
| Doxorubicin | hsa-miR-30b-5p | miRNA | sensitive | High | Ehrlich Ascites Tumor | Homo sapiens | |
| Fluorouracil | hsa-miR-30b-5p | miRNA | resistant | High | Colon Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | High | Ovarian Cancer | Homo sapiens | |
| Paroxetine | hsa-miR-30b-5p | miRNA | resistant | High | Normal | Homo sapiens | |
| Carboplatin | hsa-miR-30b-5p | miRNA | sensitive | High | Hepatocellular Carcinoma | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | High | Hepatocellular Carcinoma | Homo sapiens | |
| Vincristine | hsa-miR-30b-5p | miRNA | sensitive | High | Hepatocellular Carcinoma | Homo sapiens | |
| Doxorubicin | hsa-miR-30b-5p | miRNA | sensitive | High | Hepatocellular Carcinoma | Homo sapiens | |
| Mitomycin C | hsa-miR-30b-5p | miRNA | sensitive | High | Hepatocellular Carcinoma | Homo sapiens | |
| Oxaliplatin | hsa-miR-30b-5p | miRNA | resistant | High | Colorectal Cancer | Homo sapiens | |
| Erlotinib | hsa-miR-30b-5p | miRNA | sensitive | Low | Non-Small Cell Lung Cancer | Homo sapiens | |
| Gefitinib | hsa-miR-30b-5p | miRNA | sensitive | Low | Non-Small Cell Lung Cancer | Homo sapiens | |
| Carboplatin | hsa-miR-30b-5p | miRNA | resistant | High | Hepatocellular Carcinoma | Homo sapiens | |
| Doxorubicin | hsa-miR-30b-5p | miRNA | resistant | High | Hepatocellular Carcinoma | Homo sapiens | |
| Mitomycin C | hsa-miR-30b-5p | miRNA | resistant | High | Hepatocellular Carcinoma | Homo sapiens | |
| Gefitinib | hsa-miR-30b-5p | miRNA | resistant | Low | Non-Small Cell Lung Cancer | Homo sapiens | |
| Imatinib | hsa-miR-30b-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
| Doxorubicin | hsa-miR-30b-5p | miRNA | sensitive | High | Gastric Cancer | Homo sapiens | |
| Aed Therapy | hsa-miR-30b-5p | miRNA | sensitive | High | Epilepsy | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | High | Ovarian Cancer | Homo sapiens | |
| Plx-4720 | hsa-miR-30b-5p | miRNA | resistant | High | Thyroid Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Platinum | hsa-miR-30b-5p | miRNA | resistant | Low | Ovarian Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | Low | Cervical Cancer | Homo sapiens | |
| Tamoxifen | hsa-miR-30b-5p | miRNA | sensitive | High | Breast Cancer | Homo sapiens | |
| Aromatase Inhibitor | hsa-miR-30b-5p | miRNA | sensitive | Low | Breast Cancer | Homo sapiens | |
| Trastuzumab | hsa-miR-30b-5p | miRNA | sensitive | Low | HER2-Positive Breast Cancer | Homo sapiens | |
| Fluorouracil | hsa-miR-30b-5p | miRNA | sensitive | High | Colorectal Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | sensitive | High | Non-Small Cell Lung Cancer | Homo sapiens | |
| Gemcitabine | hsa-miR-30b-5p | miRNA | sensitive | High | Cholangiocarcinoma | Homo sapiens | |
| Daunorubicin | hsa-miR-30b-5p | miRNA | resistant | High | Acute Promyelocytic Leukemia | Homo sapiens | |
| Fulvestrant | hsa-miR-30b-5p | miRNA | resistant | High | Breast Cancer | Homo sapiens | |
| Tamoxifen | hsa-miR-30b-5p | miRNA | resistant | High | Breast Cancer | Homo sapiens | |
| Radioactivity Iodine | hsa-miR-30b-5p | miRNA | sensitive | High | Papillary Thyroid Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | resistant | High | Ovarian Cancer | Homo sapiens | |
| Dabrafenib | hsa-miR-30b-5p | miRNA | sensitive | High | Melanoma | Homo sapiens | |
| Fluorouracil | hsa-miR-30b-5p | miRNA | resistant | High | Colorectal Cancer | Homo sapiens | |
| Carboplatin | hsa-miR-30b-5p | miRNA | resistant | Low | Ovarian Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | Low | Ovarian Cancer | Homo sapiens | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | sensitive | High | Endometrial Serous Carcinoma | Homo sapiens | |
| Dabrafenib | hsa-miR-30b-5p | miRNA | sensitive | High | Melanoma | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | Low | Non-Small Cell Lung Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | Low | Non-Small Cell Lung Cancer | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | High | Hypopharyngeal Cancer | Homo sapiens | |
| Platinum | hsa-miR-30b-5p | miRNA | sensitive | High | High-Grade Serous Ovarian Cancer | Homo sapiens | |
Network
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Drug-reponse_GEO
| Compound | ncRNA | ncRNA Type | Pattern | log2FC | p-value | Detail |
|---|---|---|---|---|---|---|
| Temozolomide | hsa-miR-30b-5p | miRNA | resistant | 0.550 | 0.012 | |
| Osimertinib | hsa-miR-30b-5p | miRNA | resistant | 1.200 | NA | |
| Vemurafenib | hsa-miR-30b-5p | miRNA | resistant | 0.317 | 6.70e-5 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | 1.300 | NA | |
| Gefitinib | hsa-miR-30b-5p | miRNA | resistant | 1.723 | NA | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | resistant | 1.573 | NA | |
| Vemurafenib | hsa-miR-30b-5p | miRNA | sensitive | -1.778 | NA | |
| Vemurafenib | hsa-miR-30b-5p | miRNA | sensitive | -1.267 | NA | |
| Vemurafenib | hsa-miR-30b-5p | miRNA | sensitive | -1.020 | NA | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | sensitive | -1.987 | NA | |
| Doxorubicin | hsa-miR-30b-5p | miRNA | resistant | 1.087 | NA | |
| Doxorubicin | hsa-miR-30b-5p | miRNA | sensitive | -1.074 | NA | |
| Exemestane | hsa-miR-30b-5p | miRNA | resistant | 0.363 | 0.002 | |
| Testosterone | hsa-miR-30b-5p | miRNA | resistant | 0.290 | 0.018 | |
| Testosterone+Anastrozole | hsa-miR-30b-5p | miRNA | resistant | 0.428 | 4.44e-4 | |
| Testosterone+Letrozole | hsa-miR-30b-5p | miRNA | resistant | 0.424 | 4.83e-4 | |
| Osimertinib | hsa-miR-30b-5p | miRNA | sensitive | -1.112 | 4.54e-5 | |
| Fluorouracil | hsa-miR-30b-5p | miRNA | sensitive | -0.701 | 0.001 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | 1.617 | 0.018 | |
| 4-Hydroxytamoxifen+Tamoxifen | hsa-miR-30b-5p | miRNA | resistant | 0.672 | 0.038 | |
| Ethanol+Tamoxifen | hsa-miR-30b-5p | miRNA | resistant | 0.808 | 0.015 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | 0.484 | 0.001 | |
| Sunitinib | hsa-miR-30b-5p | miRNA | resistant | 1.245 | NA | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | resistant | 0.373 | 0.008 | |
| Paclitaxel | hsa-miR-30b-5p | miRNA | resistant | 1.547 | 0.042 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | -0.641 | 0.001 | |
| Vemurafenib | hsa-miR-30b-5p | miRNA | sensitive | -0.535 | 2.83e-6 | |
| Bortezomib | hsa-miR-30b-5p | miRNA | sensitive | -1.090 | NA | |
| Bortezomib | hsa-miR-30b-5p | miRNA | sensitive | -0.083 | 5.98e-19 | |
| Bortezomib | hsa-miR-30b-5p | miRNA | sensitive | -0.478 | 9.21e-20 | |
| Ceritinib | hsa-miR-30b-5p | miRNA | resistant | 0.371 | 0.005 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | sensitive | -0.584 | 0.012 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | resistant | 3.830 | 0.007 | |
Network
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Drug-reponse_NCI60
| Compound | ncRNA | ncRNA type | Pattern | logFC | p-value | Detail |
|---|---|---|---|---|---|---|
| (1'S,8'R)-9',10'-dibromospiro[1,3-dithiolane-2,11'-tricyclo[6.3.1.02,7]dodeca-2,4,6,9-tetraene] | hsa-miR-30b-5p | miRNA | sensitive | -1.0712 | 0.0124 | |
| (1-(((2-amino-6-chloro-4-pyrimidinyl)amino)methyl)-3-phenylcyclobutyl)methanol | hsa-miR-30b-5p | miRNA | sensitive | -1.2346 | 0.045 | |
| (2e,4e,6z,8e)-n-(1,3-benzodioxol-5-yl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide | hsa-miR-30b-5p | miRNA | sensitive | -1.2381 | 0.001 | |
| (2s)-n-[(2r)-1-[(2,4-dimethoxyphenyl)methylamino]-1-oxopropan-2-yl]-n-methyl-1-[(2s)-3-methyl-2-[methyl-[(2s)-3-methyl-2-[[(2s)-3-methyl-2-(octanoylamino)butanoyl]amino]butanoyl]amino]butanoyl]pyrroli | hsa-miR-30b-5p | miRNA | sensitive | -1.0833 | 0.0178 | |
| (3e)-3-[(2-chloro-1-methylindol-3-yl)methylidene]-1h-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.163 | 0.0109 | |
| (3e)-3-[(2-chloro-5-methoxy-1h-indol-3-yl)methylidene]-1-phenylindol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0572 | 0.0207 | |
| (3e)-3-[(2,6-dimethylimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-1h-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0975 | 0.002 | |
| (3e)-3-[(2,6-dimethylimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-5-fluoro-1h-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0316 | 0.0105 | |
| (3e)-3-[(2,6-dimethylimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-5-methoxy-1h-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1708 | 0.0143 | |
| (3s,5s)-4-benzyl-3,5-bis(2-methoxyphenyl)hexahydro-1h-pyrrolizinium chloride | hsa-miR-30b-5p | miRNA | sensitive | -1.3068 | 0.0017 | |
| (3s,8r,9s,10r,13s,14s,16e)-3-hydroxy-10,13-dimethyl-16-[(4-nitrophenyl)methylidene]-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-17-one | hsa-miR-30b-5p | miRNA | resistant | 1.1912 | 0.0023 | |
| (3z)-3-[(2,6-dimethylimidazo[2,1-b][1,3]thiazol-5-yl)methylidene]-5-hydroxy-1-methylindol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0975 | 0.0123 | |
| (3z)-6,7-dichloro-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-1h-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0477 | 0.0071 | |
| (3z,5z)-3,5-bis[(4-methoxyphenyl)methylidene]-1,1-dimethylpiperidin-1-ium-4-one;iodide | hsa-miR-30b-5p | miRNA | sensitive | -1.0023 | 0.0256 | |
| (4-methoxyphenyl)(2,3,4-trimethoxyphenyl)methanone | hsa-miR-30b-5p | miRNA | sensitive | -1.0057 | 0.0028 | |
| (4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl)methyl 2,2-diphenylacetate | hsa-miR-30b-5p | miRNA | sensitive | -1.0868 | 0.0085 | |
| (4aR,9aR)-9-(4-methylphenyl)sulfonyl-3,4,4a,9a-tetrahydrocarbazole | hsa-miR-30b-5p | miRNA | sensitive | -1.0244 | 0.0014 | |
| (5ar,6r,8ar)-6-(1,5-dimethylhexyl)-5a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-cyclopenta[b]azepine | hsa-miR-30b-5p | miRNA | sensitive | -1.0324 | 0.0036 | |
| (5E)-3-(4-chlorophenyl)-1,1-dioxo-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0117 | 0.0252 | |
| (5E)-3-(4-chlorophenyl)-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0761 | 0.003 | |
| (5E)-3-(4-chlorophenyl)-5-[(3-phenoxyphenyl)methylidene]-2-phenyl-1,3-thiazolidin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1811 | 0.0011 | |
| (5E)-3-(4-methoxyphenyl)-1,1-dioxo-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1741 | 0.0085 | |
| (5z)-3-[4-benzoyl-2-[(4z)-5-oxo-2-phenyl-4-[(3,4,5-trimethoxyphenyl)methylidene]imidazol-1-yl]phenyl]-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]imidazol-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.015 | 0.0175 | |
| (5z)-5-[(2-chlorophenyl)methylidene]-3-(furan-2-ylmethyl)-2-phenylimidazol-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2768 | 0.0014 | |
| (7ar)-1,6-bis(4-methoxyphenyl)-7a-phenyltetrahydroimidazo[1,5-b][1,2,4]oxadiazol-2(1h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.3269 | 0.0001 | |
| (8r,9s,10r,13s,14s,16e)-10,13-dimethyl-16-[(3,4,5-trimethoxyphenyl)methylidene]-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,17-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.1836 | 0.005 | |
| (8R,9S,10R,13S,14S,16E)-10,13-dimethyl-16-[[3-(2-morpholin-4-ylethoxy)phenyl]methylidene]-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,17-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.3325 | 0.0006 | |
| (8R,9S,13S,14S,16E)-3-hydroxy-13-methyl-16-(pyridin-4-ylmethylidene)-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1253 | 0.013 | |
| (E)-1-(7-methoxy-3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | hsa-miR-30b-5p | miRNA | resistant | 1.2144 | 0.0006 | |
| (e)-1-(benzenesulfonyl)-3-(2-phenyl-1h-indol-3-yl)prop-2-en-1-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0769 | 0.0007 | |
| (E)-1-[4-(quinazolin-4-ylamino)phenyl]-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1895 | 0.0046 | |
| (e)-1-[4-[[4,6-bis(4-fluoroanilino)-1,3,5-triazin-2-yl]amino]phenyl]-3-(4-methoxyphenyl)prop-2-en-1-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2149 | 0.0006 | |
| (E)-3-(4-methoxyphenyl)-2-(4-oxo-3H-quinazolin-2-yl)prop-2-enenitrile | hsa-miR-30b-5p | miRNA | resistant | 1.0435 | 0.0002 | |
| (E)-3-[4-(dimethylamino)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0479 | 0.0084 | |
| (E)-but-2-enedioic acid;2-[4-tert-butyl-1-[(4-methylphenyl)methyl]cyclohexyl]oxy-N,N-dimethylethanamine | hsa-miR-30b-5p | miRNA | sensitive | -1.0233 | 0.0149 | |
| (E)-N-[[(17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]methyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1035 | 0.0044 | |
| (E)-N-ethyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)prop-2-enamide | hsa-miR-30b-5p | miRNA | sensitive | -1.077 | 0.0014 | |
| (ne)-n-[1-[3-(furo[2,3-b]quinolin-4-ylamino)phenyl]ethylidene]hydroxylamine | hsa-miR-30b-5p | miRNA | sensitive | -1.0519 | 0.0204 | |
| [(10R,13S,16E)-16-[[3-methoxy-4-(2-pyrrolidin-1-ylethoxy)phenyl]methylidene]-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | hsa-miR-30b-5p | miRNA | sensitive | -1.0168 | 0.0054 | |
| [(4E,6Z,8R,9R,10E,12R,13R,14R,16R)-9-carbamoyloxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-13-yl] 3-(dimethylamino)propanoate;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.1086 | 0.0007 | |
| [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate | hsa-miR-30b-5p | miRNA | sensitive | -1.0323 | 0.0051 | |
| [1-(4-butylphenyl)-2,5-dimethyl-4-(methylcarbamoyloxymethyl)pyrrol-3-yl]methyl N-methylcarbamate | hsa-miR-30b-5p | miRNA | resistant | 1.0837 | 0.0452 | |
| [3-(4-fluorophenyl)-8,9-dimethyl-2-oxo-5H-pyrano[3,2-c]chromen-5-yl] acetate | hsa-miR-30b-5p | miRNA | sensitive | -1.0149 | 0.0007 | |
| [4-[[2-(1h-indol-2-yl)-1,3-dioxolan-2-yl]methyl]-1-piperidyl]-phenyl-methanone | hsa-miR-30b-5p | miRNA | sensitive | -1.1242 | 0.014 | |
| [4-[[4-[4-(3-azidophenothiazin-10-yl)butyl]piperazin-1-yl]methyl]phenyl]-phenylmethanone;(Z)-but-2-enedioic acid | hsa-miR-30b-5p | miRNA | sensitive | -1.0366 | 0.0266 | |
| [7-benzyl-6-bromo-2,4-bis(methylsulfanyl)pyrrolo[2,3-d]pyrimidin-5-yl]methanol | hsa-miR-30b-5p | miRNA | resistant | 1.0474 | 0.0009 | |
| 1-(1-naphthylmethylene)-4-(1-naphthyl)semicarbazide | hsa-miR-30b-5p | miRNA | sensitive | -1.2184 | 0.0005 | |
| 1-(11,12,13,14-tetrachloro-17,17-dimethoxy-4-pentacyclo[7.6.1.111,14.05,16.010,15]heptadeca-1(16),2,4,6,8,12-hexaenyl)ethanone | hsa-miR-30b-5p | miRNA | sensitive | -1.0674 | 0.0004 | |
| 1-(2-(2,5-dimethoxyphenyl)ethyl)-4,5-dimethoxy-2-methylbenzene | hsa-miR-30b-5p | miRNA | sensitive | -1.2765 | 0.0227 | |
| 1-(2-chlorophenyl)sulfonyl-N-(4-phenylphenyl)piperidine-4-carboxamide | hsa-miR-30b-5p | miRNA | resistant | 1.075 | 0.0233 | |
| 1-(3-bromophenyl)-7-methoxy-3,9-dihydro[1,3]thiazolo[4,3-b]quinazoline | hsa-miR-30b-5p | miRNA | sensitive | -1.0578 | 0.0159 | |
| 1-(3-methoxyphenyl)-4-phenyl-[1,2,4]triazolo[4,3-a]quinoxaline | hsa-miR-30b-5p | miRNA | sensitive | -1.1515 | 0.0002 | |
| 1-(4-nitrobenzylidene)-4-(6-methoxy-2-naphthyl)semicarbazide | hsa-miR-30b-5p | miRNA | resistant | 1.1739 | 0.0412 | |
| 1-(acetyloxy)-2-(2-(1-(acetyloxy)-1h-benzimidazol-2-yl)phenyl)-1h-benzimidazole | hsa-miR-30b-5p | miRNA | sensitive | -1.4627 | 0.0002 | |
| 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine | hsa-miR-30b-5p | miRNA | sensitive | -1.3646 | 0.0001 | |
| 1-[(z)-benzylideneamino]-2-[(e)-benzylideneamino]guanidine | hsa-miR-30b-5p | miRNA | sensitive | -1.1777 | 0.012 | |
| 1-[10-[4-(dimethylamino)-2-methylquinolin-1-ium-1-yl]decyl]-N,N,2-trimethylquinolin-1-ium-4-amine;perchlorate | hsa-miR-30b-5p | miRNA | sensitive | -1.2644 | 0.0058 | |
| 1-[4-[5,6-bis(4-chlorophenyl)-1,2,4-triazin-3-yl]piperazin-1-yl]-2-[4-(4-methoxyphenyl)piperazin-1-yl]ethanone | hsa-miR-30b-5p | miRNA | sensitive | -1.1557 | 0.0122 | |
| 1-benzyl-3-hexadecyl-2-methylimidazolium chloride | hsa-miR-30b-5p | miRNA | sensitive | -1.1358 | 0.0008 | |
| 1-butoxy-4-(dichloromethylidene)-3,5-dimethyl-1,4-dihydrophosphinine 1-oxide | hsa-miR-30b-5p | miRNA | sensitive | -1.1876 | 0.0005 | |
| 1-ethyl-2,4,6-triphenyl-4-(trichloromethyl)pyridine | hsa-miR-30b-5p | miRNA | sensitive | -1.4089 | 0.0004 | |
| 1-methylsulfonyl-3-(1-methylsulfonyl-6,7-dihydro-5h-cyclopenta[c]pyridin-3-yl)-5,6,7,8-tetrahydroisoquinoline | hsa-miR-30b-5p | miRNA | resistant | 1.0001 | 0.0098 | |
| 1-n,1-n-diethyl-4-n-(7-phenoxyquinolin-4-yl)pentane-1,4-diamine;2-hydroxypropane-1,2,3-tricarboxylic acid | hsa-miR-30b-5p | miRNA | sensitive | -1.0215 | 0.0063 | |
| 1-N,1-N-dimethyl-4-[(E)-2-quinolin-4-ylethenyl]benzene-1,2-diamine | hsa-miR-30b-5p | miRNA | sensitive | -1.2117 | 0.0029 | |
| 1-naphthalenecarboxamide, n,n'-1,8-(octanediyl)bis- | hsa-miR-30b-5p | miRNA | resistant | 1.0229 | 0.0147 | |
| 1,1',3,3',6,7-hexahydro-8h-spiro[as-indacene-2,2'-inden]-8-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0129 | 0.0479 | |
| 1,10-dimethyl-4-(methylthio)-3-phenyl-1,10-dihydropyrazolo[3,4-b][1,5]benzodiazepine | hsa-miR-30b-5p | miRNA | sensitive | -1.0422 | 0.014 | |
| 1,2-dibenzyl-5-nitro-1,2-dihydro-3h-indazol-3-one | hsa-miR-30b-5p | miRNA | sensitive | -1.4638 | 0.0015 | |
| 1,3-bis[(4-chlorophenyl)methyl]-2-phenanthren-9-yl-1,3-diazinane | hsa-miR-30b-5p | miRNA | sensitive | -1.0794 | 0.0106 | |
| 1,3-dibenzyl-6-[(2-hydroxy-3-pyrrolidin-1-ylpropyl)amino]pyrimidine-2,4-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0112 | 0.0133 | |
| 1,3-dimethyl-2-phenyl-5-[4-(4-phenylpiperazin-1-yl)butyl]pyrrolo[3,4-c]pyrrole-4,6-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0979 | 0.0131 | |
| 1,4-benzenediamine (9ci), n-butyl-n'-phenyl- | hsa-miR-30b-5p | miRNA | sensitive | -1.216 | 0.0005 | |
| 1,4,7,10-tetraazabicyclo[5.5.2]tetradecane, 4,10-bis(phenylmethyl)- | hsa-miR-30b-5p | miRNA | sensitive | -1.5754 | 0 | |
| 11-methyl-2,12-diazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9(21),10,12,14,16,18-decaen-20-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1494 | 0.032 | |
| 15-phenyl-13,14,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2,4,6,8,11(16),14-heptaen-12-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0099 | 0.0262 | |
| 17-methyl-13,14,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2,4,6,8,11(16),14-heptaen-12-one | hsa-miR-30b-5p | miRNA | resistant | 1.2692 | 0.0001 | |
| 17-nitro-8,20-diazapentacyclo[11.7.1.02,7.09,21.014,19]henicosa-1(21),2,4,6,8,10,12,14(19),15,17-decaene | hsa-miR-30b-5p | miRNA | sensitive | -1.024 | 0.0411 | |
| 1h-indole-3-carbonitrile, 2-amino-5-(phenylthio)- | hsa-miR-30b-5p | miRNA | sensitive | -1.1071 | 0.0397 | |
| 2',6'-dibromo-2-(methoxymethyl)spiro[7,8-dihydro-6h-thieno[3,2-g]quinoline-5,4'-cyclohexa-2,5-diene]-1',4,9-trione | hsa-miR-30b-5p | miRNA | sensitive | -1.3325 | 0.0016 | |
| 2-(1h-benzimidazol-2-yl)-3,4,5,6-tetrachlorobenzohydrazide | hsa-miR-30b-5p | miRNA | sensitive | -1.1782 | 0.0004 | |
| 2-(2-(dimethylamino)ethylamino)naphthazarin | hsa-miR-30b-5p | miRNA | sensitive | -1.0425 | 0.0037 | |
| 2-(2-naphthyl)-5-methyl-1,8-naphthyridin-4(1h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.247 | 0.0053 | |
| 2-(2-naphthyl)-5,7-dimethyl-1,8-naphthyridin-4(1h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.472 | 0.0001 | |
| 2-(3-chlorophenyl)-4-phenyl-5,7-dihydropyrido[3,2-d][1]benzazepin-6-one | hsa-miR-30b-5p | miRNA | resistant | 1.3858 | 0.0001 | |
| 2-(3-chlorophenyl)-4-phenyl-5,7-dihydropyrido[3,2-d][1]benzazepine-6-thione | hsa-miR-30b-5p | miRNA | resistant | 1.2742 | 0.0016 | |
| 2-(4-methoxyphenyl)-1-methylene-3-(p-tolyl)pyrazino[1,2-a]benzimidazole | hsa-miR-30b-5p | miRNA | sensitive | -1.1354 | 0.0046 | |
| 2-(4-methoxyphenyl)-5-(p-tolyl)-4,5,10,10b-tetrahydro-3ah-pyrrolo[3,4-a]carbazole-1,3-dione | hsa-miR-30b-5p | miRNA | resistant | 1.1303 | 0.0292 | |
| 2-(4-methoxyphenyl)-5-methyl-1,8-naphthyridin-4(1h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2431 | 0.003 | |
| 2-(6-benzoyl-1h-benzimidazol-2-yl)-3,4,5,6-tetrachloro-n-(furan-2-yl)benzamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0926 | 0.0005 | |
| 2-[(2-aminophenyl)sulfanylmethyl]-3-methoxy-xanthen-9-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1909 | 0.0003 | |
| 2-[(e)-3,5-dimethoxybenzylidene]-6,7-dimethoxytetralin-1-one | hsa-miR-30b-5p | miRNA | sensitive | -1.013 | 0.009 | |
| 2-[[4-[(2-amino-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]pentanedioic acid | hsa-miR-30b-5p | miRNA | resistant | 1.044 | 0.0029 | |
| 2-[[5-methoxy-2-(4-methoxyphenyl)-1h-indol-3-yl]methylidene]propanedinitrile | hsa-miR-30b-5p | miRNA | sensitive | -1.0157 | 0.0139 | |
| 2-[1-(4-chlorophenyl)sulfonylindol-3-yl]-2-oxo-N-pyridin-4-ylacetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0126 | 0.0486 | |
| 2-[2-hydroxyethyl-[3-[(2-methoxy-6-nitroacridin-9-yl)amino]propyl]amino]ethanol | hsa-miR-30b-5p | miRNA | sensitive | -1.0613 | 0.0087 | |
| 2-[4-(3-ethyl-2,6-dioxopiperidin-3-yl)phenyl]-5-nitrobenzo[de]isoquinoline-1,3-dione | hsa-miR-30b-5p | miRNA | resistant | 1.1087 | 0.013 | |
| 2-[4-(4-chlorophenyl)piperazin-1-yl]-1-[4-(5,6-diphenyl-1,2,4-triazin-3-yl)piperazin-1-yl]ethanone | hsa-miR-30b-5p | miRNA | sensitive | -1.1145 | 0.0001 | |
| 2-[4-[4-(6-morpholin-4-yl-1H-benzimidazol-2-yl)phenoxy]butyl]benzo[de]isoquinoline-1,3-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.1301 | 0.0065 | |
| 2-[5-[4-[5-[4-(6-morpholin-4-yl-1H-benzimidazol-2-yl)phenoxy]pentyl]piperazin-1-yl]pentyl]benzo[de]isoquinoline-1,3-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0677 | 0.0003 | |
| 2-acetyl-1,2-dihydroellipticine | hsa-miR-30b-5p | miRNA | resistant | 1.1008 | 0.0005 | |
| 2-acetyl-5-phenyl-4-[(e)-(3,4,5-trimethoxyphenyl)methylideneamino]-1,2,4-triazol-3-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0583 | 0.0287 | |
| 2-amino-4-(3-methoxyphenyl)-10-methyl-7,7-dioxo-5,6-dihydro-[1]benzothiepino[4,5-c]pyridine-1-carbonitrile | hsa-miR-30b-5p | miRNA | sensitive | -1.2686 | 0.0097 | |
| 2-amino-6-(benzylamino)-4-(2-chlorophenyl)pyridine-3,5-dicarbonitrile | hsa-miR-30b-5p | miRNA | resistant | 1.0133 | 0.019 | |
| 2-isopropyl-11-oxo-n-[2-(4-phenylpiperazin-1-yl)ethyl]-11h-pyrido[2,1-b]quinazoline-8-carboxamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0673 | 0.0013 | |
| 2-methyl-1-[10-[(2-methylquinolin-4-yl)amino]decyl]quinolin-1-ium-4-amine;chloride;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.2164 | 0.01 | |
| 2-methyl-4,4-diphenyl-1,4-benzoxaphosphinin-4-ium;bromide | hsa-miR-30b-5p | miRNA | sensitive | -1.0649 | 0.0245 | |
| 2-n-[3-(diethylaminomethyl)-4-methoxyphenyl]-4-n-[4-(dimethylamino)cyclohexyl]quinazoline-2,4-diamine;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.3829 | 0.0002 | |
| 2-naphthalen-2-yl-1h-[1,8]naphthyridin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.4587 | 0.0003 | |
| 2,2'-spirobi[3,6,7,8-tetrahydro-1H-cyclopenta[g]naphthalene]-5,5'-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.28 | 0.0011 | |
| 2,2'-spirobi[indane]-5,5'-dicarbaldehyde | hsa-miR-30b-5p | miRNA | sensitive | -1.0583 | 0.0286 | |
| 2,2'(1h,1'h)-spirobi[s-indacen]-1-one, 4'-acetyl-3,3',5,5',6,6',7,7'-octahydro- | hsa-miR-30b-5p | miRNA | sensitive | -1.1339 | 0.0003 | |
| 2,2,2-trifluoro-N-[3-[naphthalen-2-ylmethyl-[4-[naphthalen-2-ylmethyl-[3-[(2,2,2-trifluoroacetyl)amino]propyl]amino]butyl]amino]propyl]acetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1111 | 0.0004 | |
| 2,5-dibenzyl-2-undecyloctahydro-1h-pyrrolo[3,4-c]pyridin-2-ium bromide | hsa-miR-30b-5p | miRNA | sensitive | -1.256 | 0.0006 | |
| 2,5,9,12-tetrathiabicyclo[11.4.0]heptadeca-1(13),14,16-triene-15,16-dicarbonitrile | hsa-miR-30b-5p | miRNA | resistant | 1.1297 | 0.0101 | |
| 2,6,13,17-tetrazaheptacyclo[15.12.0.01,25.03,16.05,14.07,12.018,23]nonacosa-3,5,7,9,11,13,15,18(23)-octaene | hsa-miR-30b-5p | miRNA | sensitive | -1.2808 | 0.0007 | |
| 2,7-bis(1-hydroxyethyl)thieno[2,3-f][1]benzothiole-4,8-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.1129 | 0.0247 | |
| 2,7-bis(methoxycarbonylmethyl)-10-methylphenothiazine | hsa-miR-30b-5p | miRNA | sensitive | -1.2896 | 0.0048 | |
| 296cfo5qf6 | hsa-miR-30b-5p | miRNA | sensitive | -1.105 | 0.0278 | |
| 2h-1-benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- | hsa-miR-30b-5p | miRNA | resistant | 1.0634 | 0.0031 | |
| 3-(2-chloro-5-methoxy-1h-indol-3-ylmethylene)-5-methoxy-6-methyl-1,3-dihydro-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1419 | 0.012 | |
| 3-(2-quinolyl)-6-(3,4,5-trimethoxyphenyl)pyridine-2,4-diol | hsa-miR-30b-5p | miRNA | sensitive | -1.3256 | 0.0193 | |
| 3-(3-fluorophenyl)-n-pyridin-3-yl-2h-pyrazolo[3,4-d][1,3]thiazol-5-amine | hsa-miR-30b-5p | miRNA | sensitive | -1.2084 | 0.0037 | |
| 3-(3-methoxyphenyl)-2-(3-phenoxyphenyl)-1,3-thiazolidin-4-one 1,1-dioxide | hsa-miR-30b-5p | miRNA | sensitive | -1.1643 | 0.0252 | |
| 3-(4-methoxy-2-methylphenyl)naphthol [2,1-c]furan-1(3h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1432 | 0.0099 | |
| 3-(4-methoxyphenyl)-1-[(e)-2-(2-thienyl)vinyl]pyrazino[1,2-a]benzimidazole | hsa-miR-30b-5p | miRNA | sensitive | -1.4168 | 0.0003 | |
| 3-(4-methoxyphenyl)-1-methylidene-2-phenylpyrazino[1,2-a]benzimidazole | hsa-miR-30b-5p | miRNA | sensitive | -1.039 | 0.0075 | |
| 3-(4-methoxyphenyl)-4-methyl-8-pyrrolidin-1-yl-8H-thieno[2,3-b]pyrrolizin-4-ium;iodide | hsa-miR-30b-5p | miRNA | sensitive | -1.1436 | 0.0201 | |
| 3-[(2,3-dimethoxyphenyl)methyl]-7,8-dimethoxy-5-methylsulfanyl-2,5-dihydro-1H-3-benzazepin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2447 | 0.0093 | |
| 3-[5-[2-[2-(4,4-dimethyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)ethylamino]pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenol | hsa-miR-30b-5p | miRNA | sensitive | -1.2658 | 0.0105 | |
| 3-chloroindolo[2,1-b]quinazoline-6,12-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0625 | 0.0005 | |
| 3-methyl-1-phenyl-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2326 | 0.0007 | |
| 3-methyl-5-[(2,3,4,5,6-pentafluorophenyl)-[2,3,5,6-tetrafluoro-4-[(3-methyl-1,2-oxazol-5-yl)methyl]phenyl]methyl]-1,2-oxazole | hsa-miR-30b-5p | miRNA | sensitive | -1.1005 | 0.0019 | |
| 3-pyridinecarboxamide, n-[3-(phenylsulfonyl)-2-thienyl]- | hsa-miR-30b-5p | miRNA | sensitive | -1.148 | 0.0034 | |
| 3,19-(4-acetamido)benzylidineandrographolide | hsa-miR-30b-5p | miRNA | sensitive | -1.0735 | 0.0007 | |
| 3,5-dichloro-N-[4-[3-(4-chloro-3-hydroxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]benzamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0785 | 0.0353 | |
| 4-(2-(((6-bromo-1,3-benzodioxol-5-yl)methyl)amino)ethyl)phenol | hsa-miR-30b-5p | miRNA | sensitive | -1.1013 | 0.008 | |
| 4-(2-azidophenothiazin-10-yl)-N,N-dimethylbutan-1-amine;oxalic acid | hsa-miR-30b-5p | miRNA | sensitive | -1.0212 | 0.0041 | |
| 4-(3h-[1,3]thiazolo[3,4-a]benzimidazol-1-yl)phenyl acetate | hsa-miR-30b-5p | miRNA | sensitive | -1.337 | 0 | |
| 4-(4-bromophenyl)-2-phenyl-5,7-dihydropyrido[3,2-d][1]benzazepine-6-thione | hsa-miR-30b-5p | miRNA | resistant | 1.2972 | 0.0016 | |
| 4-(4-chlorophenyl)-N-(2-methoxyphenyl)-3-prop-2-enyl-1,3-thiazol-2-imine;hydrobromide | hsa-miR-30b-5p | miRNA | sensitive | -1.7409 | 0 | |
| 4-(4,7-dimethoxy-1,3-benzodioxol-5-yl)-5-(4-methoxyphenyl)-2H-triazole | hsa-miR-30b-5p | miRNA | sensitive | -1.0656 | 0.0116 | |
| 4-(6-methoxynaphthalen-2-yl)-3-(3,4,5-trimethoxyphenyl)pyran-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2152 | 0.0175 | |
| 4-(dichloromethylidene)-1-ethoxy-3,5-dimethyl-1,4-dihydrophosphinine 1-oxide | hsa-miR-30b-5p | miRNA | sensitive | -1.053 | 0.0319 | |
| 4-[(4z)-5-oxo-4-[(4-phenoxyphenyl)methylidene]-2-phenylimidazol-1-yl]-n-(1,3-thiazol-2-yl)benzenesulfonamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1631 | 0.0004 | |
| 4-[(5-methyl-1,2-oxazol-3-yl)amino]naphthalene-1,2-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0683 | 0.0202 | |
| 4-[2-(3-aminopropylamino)ethyldisulfanyl]butane-1-sulfinic acid;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.029 | 0.0201 | |
| 4-[2-[(2Z)-2-[3-ethyl-4-hydroxy-5-(phenyliminomethyl)-1,3-thiazol-2-ylidene]hydrazinyl]-1,3-thiazol-4-yl]benzene-1,2-diol | hsa-miR-30b-5p | miRNA | sensitive | -1.0317 | 0.033 | |
| 4-[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxopyridazin-1-yl]ethoxy]-4-oxobutanoic acid | hsa-miR-30b-5p | miRNA | sensitive | -1.209 | 0.0122 | |
| 4-[2-[4-[3-(4-chlorophenyl)-1-methylene-pyrazino[1,2-a]benzimidazol-2-yl]phenoxy]ethyl]morpholine | hsa-miR-30b-5p | miRNA | sensitive | -1.0752 | 0.0042 | |
| 4-[4-(3-methoxyphenyl)piperazin-1-yl]-5H-pyrrolo[3,2-d]pyrimidine | hsa-miR-30b-5p | miRNA | sensitive | -1.1638 | 0.0027 | |
| 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]cyclohexyl]oxy-N-methylpyridine-2-carboxamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1594 | 0.0135 | |
| 4-acetylspiro[1,3,5,6,7,8-hexahydrocyclopenta[b]naphthalene-2,2'-3,6,7,8-tetrahydro-1h-cyclopenta[g]naphthalene]-5'-one | hsa-miR-30b-5p | miRNA | sensitive | -1.4139 | 0.0012 | |
| 4-methyl-1,1-diphenyl-1,2,3,4-tetrahydrobenzo(h)phosphinolinium hexafluorophosphate | hsa-miR-30b-5p | miRNA | sensitive | -1.052 | 0.0217 | |
| 4-methyl-n'-[7-methyl-8-(3,4,5-trimethoxyphenyl)-7,8-dihydro-6h-[1,3]dioxolo[4,5-g]chromen-6-yl]benzenesulfonohydrazide | hsa-miR-30b-5p | miRNA | sensitive | -1.0446 | 0.0338 | |
| 4-methyl-n-[(4-phenyl-[1,2,4]triazolo[4,3-a]quinoxalin-1-yl)methyl]aniline | hsa-miR-30b-5p | miRNA | sensitive | -1.0391 | 0.0362 | |
| 4-morpholinecarbodithioic acid, antimony complex | hsa-miR-30b-5p | miRNA | sensitive | -1.0653 | 0.0082 | |
| 4(1h)-quinazolinone, 2,3-dihydro-2-(1-naphthyl)- (8ci) | hsa-miR-30b-5p | miRNA | sensitive | -1.0233 | 0.0418 | |
| 4,4'-[oxybis(4,1-phenylene)]dipyridine | hsa-miR-30b-5p | miRNA | sensitive | -1.0787 | 0.0069 | |
| 4,5-bis(4-methoxyphenyl)-1h-imidazol-2(5h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.3386 | 0.0015 | |
| 5-[2-(2,5-dimethoxyphenyl)ethynyl]-N-[2-(4-fluorophenyl)ethyl]-2-methoxybenzamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0296 | 0.0023 | |
| 5-[2-(4-chlorophenyl)ethyl]-6,7-dimethyl-1,1-dioxo-3-phenyl-3,4-dihydro-2h-pyrrolo[3,2-b][1,4]thiazine-2-carbonitrile | hsa-miR-30b-5p | miRNA | sensitive | -1.1068 | 0.0058 | |
| 5-{[2-(cyclobutylcarbonyl)-6-methoxy-1,2,3,4,5,8-hexahydroisoquinolin-1-yl]methyl}-2-methoxyphenol | hsa-miR-30b-5p | miRNA | sensitive | -1.4105 | 0.0013 | |
| 5-benzyl-4-imino-6-methyl-n-phenyl-7h-pyrrolo[2,3-d]pyrimidin-3-amine | hsa-miR-30b-5p | miRNA | sensitive | -1.3916 | 0.0005 | |
| 5-benzyl-5h-benzo[b]phosphindole 5-oxide | hsa-miR-30b-5p | miRNA | sensitive | -1.3625 | 0.0024 | |
| 5-chroman-6-yl-2-(4-pyridyl)oxazole | hsa-miR-30b-5p | miRNA | sensitive | -1.3137 | 0.0011 | |
| 5-hydroxy-3-phenylpyrano[3,2-c]chromen-2(5h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.4469 | 0.0003 | |
| 5,7-dichloro-3-hydroxy-3-[2-(3-nitrophenyl)-2-oxoethyl]-1,3-dihydro-2h-indol-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.2177 | 0.0052 | |
| 6-(1-benzofuran-2-yl)-4-(4-chlorophenyl)-2-methylsulfanylpyridine-3-carbonitrile | hsa-miR-30b-5p | miRNA | resistant | 1.1815 | 0.0016 | |
| 6-(3-chloropropyl)-2,3-dimethoxy-5,11-dioxoindeno[1,2-c]isoquinoline-9-carbonitrile | hsa-miR-30b-5p | miRNA | resistant | 1.1035 | 0.0068 | |
| 6-(4-ethylphenyl)-2-benzenesulfonamidepyridazine-3(2h)-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0894 | 0.0105 | |
| 6-[(2e)-2-(4-fluorophenyl)-2-hydroxyiminoethoxy]-2-phenylchromen-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0099 | 0.0408 | |
| 6-[3-(4-aminobutylamino)propyl]-13-[3-[(2-methoxyphenyl)methylamino]propyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone | hsa-miR-30b-5p | miRNA | sensitive | -1.2377 | 0.0374 | |
| 6-[3-[4-(3-aminopropylamino)butylamino]propyl]-13-[3-[(2-methoxyphenyl)methylamino]propyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone | hsa-miR-30b-5p | miRNA | sensitive | -1.0745 | 0.0371 | |
| 6-amino-1-[3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-yl]-5h-triazolo[4,5-c]pyridin-4-one | hsa-miR-30b-5p | miRNA | sensitive | -1.091 | 0.0154 | |
| 6-amino-7-(4-chlorophenyl)sulfonyl-5-[(4-methoxyphenyl)methyl]pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile | hsa-miR-30b-5p | miRNA | resistant | 1.0975 | 0.0252 | |
| 6-chloro-1-(2-nitrophenyl)sulfonyl-3,4-dihydro-2h-quinoline | hsa-miR-30b-5p | miRNA | sensitive | -1.0024 | 0.0005 | |
| 6-chloro-1-[(4-chloro-2-nitrophenyl)sulfonyl]-1,2,3,4-tetrahydroquinoline | hsa-miR-30b-5p | miRNA | sensitive | -1.0788 | 0.0001 | |
| 6-chloro-3-[(Z)-[2-(4-methoxyphenyl)benzimidazol-5-ylidene]methyl]-1H-indol-2-ol | hsa-miR-30b-5p | miRNA | sensitive | -1.1398 | 0.0005 | |
| 6-chloro-3-imidazo[1,2-a]pyridin-2-ylchromen-2-one | hsa-miR-30b-5p | miRNA | resistant | 1.1812 | 0.0019 | |
| 6,6-dimethyl-1-[3-[(3-nitrophenyl)methoxy]phenyl]-1,3,5-triazine-2,4-diamine | hsa-miR-30b-5p | miRNA | sensitive | -1.0879 | 0.007 | |
| 6,7-dimethyl-5,8-diazatetracyclo[10.2.2.02,11.04,9]hexadeca-2,4,6,8,10,13-hexaene-3,10-diol | hsa-miR-30b-5p | miRNA | sensitive | -1.0104 | 0.0024 | |
| 6,8-dichloro-2-imino-n-naphthalen-1-ylchromene-3-carboxamide | hsa-miR-30b-5p | miRNA | resistant | 1.1906 | 0.0028 | |
| 7'-but-3-en-2-yl-7'-(3-phenylmethoxypropyl)spiro[1,3-dioxolane-2,2'-3,4,7a,8,9,10-hexahydro-1h-cyclopenta[i]indolizine]-6'-thione | hsa-miR-30b-5p | miRNA | sensitive | -1.272 | 0.002 | |
| 7-[(3-fluorophenyl)methoxy]-9-[(3-fluorophenyl)methyl]-2-[(4-fluorophenyl)methyl]-1-methylpyrido[3,4-b]indol-2-ium | hsa-miR-30b-5p | miRNA | sensitive | -1.0003 | 0.0112 | |
| 7-bromo-2,4,7-triphenyl-6H-benzo[a]quinolizin-5-ium;bromide | hsa-miR-30b-5p | miRNA | sensitive | -1.1658 | 0.007 | |
| 7,17-dimethoxy-10,14-dithia-3,12-diaza-1-azoniapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),4(9),5,7,11,15(20),16,18-octaene;iodide | hsa-miR-30b-5p | miRNA | sensitive | -1.0807 | 0.035 | |
| 9-(2,4-dimethoxyphenyl)-6,9-dihydro-8h-[1,3]dioxolo[4,5-g]furo[3,4-b]chromen-8-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0733 | 0.0167 | |
| 9-(oxan-2-yl)-1,3-diphenyl-2-sulfanylidenepurin-6-one | hsa-miR-30b-5p | miRNA | resistant | 1.1509 | 0.0023 | |
| 9-[(2e)-2-(4-chlorophenyl)-2-hydroxyiminoethoxy]chromeno[3,4-b]chromene-6,12-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0455 | 0.0125 | |
| 9-[2-(2,5-dimethylpyrrol-1-yl)phenyl]-7-hydroxy-5,6-di(propan-2-yloxy)-3-oxa-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12),10-tetraen-2-one | hsa-miR-30b-5p | miRNA | sensitive | -1.1275 | 0.001 | |
| 9-isobutyl-6-(((2-methyl-1-naphthyl)methyl)thio)-9h-purin-2-amine | hsa-miR-30b-5p | miRNA | sensitive | -1.0678 | 0.048 | |
| 9-methyl-2-[4-(4-phenylpiperazin-1-yl)butyl]-3,4-dihydropyrido[3,4-b]indol-1-one | hsa-miR-30b-5p | miRNA | sensitive | -1.0779 | 0.0155 | |
| 9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaene-4,5,14,15-tetrol | hsa-miR-30b-5p | miRNA | sensitive | -1.2837 | 0.004 | |
| A817740 | hsa-miR-30b-5p | miRNA | sensitive | -1.1733 | 0.0115 | |
| Abiraterone | hsa-miR-30b-5p | miRNA | sensitive | -1.0388 | 0.0113 | |
| Acetic acid, [1,4,7,10-tetraazacyclododecane-1,7-diyl]bis | hsa-miR-30b-5p | miRNA | sensitive | -1.0563 | 0.0006 | |
| Aminopyrimidine-ch3 | hsa-miR-30b-5p | miRNA | sensitive | -1.1647 | 0.003 | |
| Antineoplastic-615538 | hsa-miR-30b-5p | miRNA | sensitive | -1.0733 | 0.0236 | |
| Austrocortirubin | hsa-miR-30b-5p | miRNA | sensitive | -1.0581 | 0.0248 | |
| Baccharin | hsa-miR-30b-5p | miRNA | sensitive | -1.0776 | 0.0333 | |
| Baccharinol | hsa-miR-30b-5p | miRNA | sensitive | -1.0728 | 0.0126 | |
| Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | hsa-miR-30b-5p | miRNA | sensitive | -1.2404 | 0.0115 | |
| Benzimidazolo[2,1-b][1,3,5]benzothiadiazepin-12-amine;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.0505 | 0.0129 | |
| Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- | hsa-miR-30b-5p | miRNA | sensitive | -1.044 | 0.0251 | |
| Benzyl (2s)-2-[methyl-[(2s)-1-[(2s)-3-methyl-2-[methyl-[3-methyl-2-[methyl-[(2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoyl]amino]butanoyl]amino]butanoyl]pyrrolidine-2-carbonyl]amino]- | hsa-miR-30b-5p | miRNA | sensitive | -1.0674 | 0.0004 | |
| Blastmycin | hsa-miR-30b-5p | miRNA | sensitive | -1.0439 | 0.0104 | |
| Cbmicro_021216 | hsa-miR-30b-5p | miRNA | sensitive | -1.1534 | 0.0011 | |
| Chemdivam_000505 | hsa-miR-30b-5p | miRNA | sensitive | -1.0885 | 0.0052 | |
| Chimaphilin | hsa-miR-30b-5p | miRNA | sensitive | -1.1334 | 0.0125 | |
| Cis-dichlorobis(4-methoxyphenethylamine)platinum(ii) | hsa-miR-30b-5p | miRNA | sensitive | -1.0201 | 0.0035 | |
| Clothixamide maleate | hsa-miR-30b-5p | miRNA | sensitive | -1.0143 | 0.0057 | |
| Cuspidatin c | hsa-miR-30b-5p | miRNA | sensitive | -1.1197 | 0.0004 | |
| Cyano pyridine -p-ch3 | hsa-miR-30b-5p | miRNA | sensitive | -1.074 | 0.0325 | |
| Di-p-tolyliodinium bromide | hsa-miR-30b-5p | miRNA | sensitive | -1.1048 | 0.0128 | |
| Diethyl 2-[[2-[4-(3-thiophen-2-ylquinoxalin-2-yl)oxyphenyl]acetyl]amino]pentanedioate | hsa-miR-30b-5p | miRNA | resistant | 1.1854 | 0.0005 | |
| Diethyl 2-[[4-[(3-ethoxycarbonylquinoxalin-2-yl)amino]benzoyl]amino]pentanedioate | hsa-miR-30b-5p | miRNA | resistant | 1.0295 | 0.0103 | |
| Diethyl 4-hydroxy-2-(4-methoxyphenyl)-6-oxo-4-phenyl-1,3-cyclohexanedicarboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.0031 | 0.0267 | |
| Diethylcyanine | hsa-miR-30b-5p | miRNA | sensitive | -1.1193 | 0.0101 | |
| Dromostanolone propionate | hsa-miR-30b-5p | miRNA | sensitive | -1.0931 | 0.0082 | |
| Ethyl (4s)-4-amino-5-[[(2r)-3-[4-[bis(2-chloroethyl)amino]phenyl]-1-ethoxy-1-oxopropan-2-yl]amino]-5-oxopentanoate;2,2,2-trifluoroacetic acid | hsa-miR-30b-5p | miRNA | resistant | 1.2605 | 0.0119 | |
| Ethyl (e)-2-cyano-3-[5'-ethyl-6'-(1-hydroxyethyl)-2,2'-spirobi[1,3-dihydroindene]-5-yl]prop-2-enoate | hsa-miR-30b-5p | miRNA | sensitive | -1.1349 | 0.0066 | |
| Ethyl (E)-3-(6-methoxy-1-thiophen-3-yl-3,4-dihydronaphthalen-2-yl)prop-2-enoate | hsa-miR-30b-5p | miRNA | sensitive | -1.2349 | 0.0108 | |
| Ethyl 2-((4-(2-methyl-4-oxo-3(4h)-quinazolinyl)phenyl)hydrazono)-3-oxobutanoate | hsa-miR-30b-5p | miRNA | sensitive | -1.3194 | 0.0049 | |
| Ethyl 3-(4-fluoroanilino)quinoxaline-2-carboxylate | hsa-miR-30b-5p | miRNA | resistant | 1.0672 | 0.0006 | |
| Ethyl 4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,3,5,7,9(17),13,15-heptaene-10-carboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.2526 | 0.0093 | |
| Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.0996 | 0.0037 | |
| Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.1907 | 0.0042 | |
| Ethyl 6-methyl-2-(4-methylbenzyl)-1-oxo-2-indanecarboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.5184 | 0.0006 | |
| Ethyl N-(5-amino-3-phenylpyrido[3,4-e][1,2,4]triazin-7-yl)carbamate;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.1141 | 0.0053 | |
| Gw410563a | hsa-miR-30b-5p | miRNA | resistant | 1.0383 | 0.0056 | |
| Gw627512b | hsa-miR-30b-5p | miRNA | sensitive | -1.1035 | 0.0277 | |
| Herveline o | hsa-miR-30b-5p | miRNA | sensitive | -1.4318 | 0 | |
| Hookerianamide k | hsa-miR-30b-5p | miRNA | sensitive | -1.0213 | 0.0149 | |
| Idaayixnilonem-uhfffaoysa-n | hsa-miR-30b-5p | miRNA | sensitive | -1.0878 | 0.0032 | |
| Iejimalide a. | hsa-miR-30b-5p | miRNA | sensitive | -1.2502 | 0.0008 | |
| Insariotoxin | hsa-miR-30b-5p | miRNA | sensitive | -1.0887 | 0.0052 | |
| Isatin dr | hsa-miR-30b-5p | miRNA | sensitive | -1.1938 | 0.0065 | |
| Isothan | hsa-miR-30b-5p | miRNA | sensitive | -1.1395 | 0.0027 | |
| J3.519.594g | hsa-miR-30b-5p | miRNA | sensitive | -1.0262 | 0.0251 | |
| J3.547.609a | hsa-miR-30b-5p | miRNA | sensitive | -1.077 | 0.0133 | |
| Juncusol deriv (compound 1) | hsa-miR-30b-5p | miRNA | sensitive | -1.1155 | 0.0021 | |
| Kinetin riboside | hsa-miR-30b-5p | miRNA | resistant | 1.1644 | 0.0164 | |
| Kuc100232 | hsa-miR-30b-5p | miRNA | sensitive | -1.0048 | 0.0278 | |
| Laurodin | hsa-miR-30b-5p | miRNA | sensitive | -1.0136 | 0.0277 | |
| Mecal | hsa-miR-30b-5p | miRNA | sensitive | -1.1101 | 0.0004 | |
| Methyl-[2-methyl-2-(4-methylphenyl)propyl]-diphenylphosphanium;iodide | hsa-miR-30b-5p | miRNA | sensitive | -1.1416 | 0.0082 | |
| Methyl (2E)-2-methoxyimino-2-[2-[[2-(trifluoromethyl)phenoxy]methyl]phenyl]acetate | hsa-miR-30b-5p | miRNA | sensitive | -1.125 | 0.0057 | |
| Methyl (E)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)prop-2-enoate | hsa-miR-30b-5p | miRNA | sensitive | -1.0121 | 0.0187 | |
| Methyl (e)-3-[2-[[methyl-(4-methylphenyl)-oxo-lambda6-sulfanylidene]amino]phenyl]prop-2-enoate | hsa-miR-30b-5p | miRNA | sensitive | -1.2078 | 0.0037 | |
| Methyl 2-((1-oxo-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methyl)benzoate | hsa-miR-30b-5p | miRNA | sensitive | -1.1509 | 0.0068 | |
| Methyl 2-(2,3-dihydro-1H-inden-5-ylmethyl)-1-oxo-3,6,7,8-tetrahydro-as-indacene-2-carboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.256 | 0.0008 | |
| Methyl 2-[3-methoxy-2-(4-methylbenzyl)-3-oxopropyl]-5-methylbenzoate | hsa-miR-30b-5p | miRNA | sensitive | -1.0928 | 0.0086 | |
| Methyl 4-[(1,4-dihydroxynaphthalen-2-yl)methylamino]benzoate | hsa-miR-30b-5p | miRNA | sensitive | -1.1526 | 0.0048 | |
| Methyl 7-oxospiro[1,2,3,5-tetrahydro-s-indacene-6,6'-2,3,5,7-tetrahydro-1h-s-indacene]-4'-carboxylate | hsa-miR-30b-5p | miRNA | sensitive | -1.0781 | 0.0114 | |
| Methyl n-[6-(methoxycarbonylamino)pyren-1-yl]carbamate;methyl n-[8-(methoxycarbonylamino)pyren-1-yl]carbamate | hsa-miR-30b-5p | miRNA | sensitive | -1.0471 | 0.0396 | |
| Methyl n-[6-[(4-fluorophenyl)sulfonylamino]-1h-benzimidazol-2-yl]carbamate | hsa-miR-30b-5p | miRNA | sensitive | -1.2932 | 0.0119 | |
| Midostaurin | hsa-miR-30b-5p | miRNA | resistant | 1.0367 | 0.0163 | |
| N'-(4-chloroanilino)pyrazine-2-carboximidamide | hsa-miR-30b-5p | miRNA | sensitive | -1.098 | 0.0009 | |
| N'-[3-[[(4r)-4-[(3r,5r,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-tris(3-aminopropoxy)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentyl]amino]propyl]p | hsa-miR-30b-5p | miRNA | sensitive | -1.0894 | 0.0125 | |
| N'-benzylidene-4-((1-methyl-2,5-dioxo-4-imidazolidinylidene)methyl)benzenesulfonohydrazide | hsa-miR-30b-5p | miRNA | sensitive | -1.1132 | 0.0155 | |
| N-(1,4-dioxido-1,2,4-benzotriazine-1,4-diium-3-yl)-N',N'-diethylethane-1,2-diamine;2,2,2-trifluoroacetic acid | hsa-miR-30b-5p | miRNA | sensitive | -1.0794 | 0.0222 | |
| N-(3-chloro-1,4-dioxonaphthalen-2-yl)-2-(4-hydroxy-2-oxochromen-3-yl)-2-oxoacetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1944 | 0.038 | |
| N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-[2-[(3,4-dioxonaphthalen-2-yl)amino]phenyl]-2,4-dioxobutanamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1677 | 0.0153 | |
| N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide | hsa-miR-30b-5p | miRNA | sensitive | -1.2402 | 0.0089 | |
| N-(4-methoxyphenyl)-3-[4-[(4-methylphenyl)diazenyl]-3,5-diphenylpyrazol-1-yl]-3-oxopropanamide | hsa-miR-30b-5p | miRNA | resistant | 1.1542 | 0.0071 | |
| N-[(r)-1-phenylethyl]-4-[[[3-(3-phenoxyphenyl)acryloyl]amino]methyl]benzamide | hsa-miR-30b-5p | miRNA | resistant | 1.281 | 0.0013 | |
| N-[(Z)-(3-butyl-4-phenyl-1,3-thiazol-2-ylidene)amino]-2-(2-methylbenzimidazol-1-yl)acetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.1145 | 0.0041 | |
| N-[1-(benzenesulfonyl)-3-methyl-7-phenylmethoxyindol-5-yl]methanesulfonamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0369 | 0.0037 | |
| N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0601 | 0.0356 | |
| N-[2-(3,4-dichlorophenyl)ethyl]-n,n'-dimethyl-n'-(2-pyrrolidin-1-ylethyl)ethane-1,2-diamine;hydrobromide | hsa-miR-30b-5p | miRNA | sensitive | -1.1737 | 0.0006 | |
| N-[2-(4-acetylpiperazin-1-yl)ethyl]-3-(3-chloro-5-hydroxyphenyl)-4-pyridin-4-ylpyrazole-1-carboxamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0953 | 0.0052 | |
| N-[2-[(E)-2-(4-methoxyphenyl)ethenyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.3679 | 0.0025 | |
| N-[3-[2-[(7-chloroquinolin-4-yl)amino]ethyl-ethylamino]propyl]-2-[7-(dimethylamino)-2-oxochromen-4-yl]acetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0563 | 0.013 | |
| N-[3-[4-[4-(3-azidophenothiazin-10-yl)butyl]piperazin-1-yl]-3-oxopropyl]-2-(4-benzoylphenyl)acetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.2635 | 0.0203 | |
| N-[6'-(diethylamino)-3-oxospiro[2-benzofuran-1,9'-xanthene]-2'-yl]-N-phenylacetamide | hsa-miR-30b-5p | miRNA | sensitive | -1.0419 | 0 | |
| N,n'-bis(salicylideneamino)oxamide | hsa-miR-30b-5p | miRNA | resistant | 1.2199 | 0.022 | |
| N,N'-bis[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]octanediamide;hydrochloride | hsa-miR-30b-5p | miRNA | sensitive | -1.1084 | 0.0239 | |
| N,n-dibenzyl-4-(4-hydroxy-2,6-dimethyl-5-pyrimidinyl)-1-piperazinesulfonamide | hsa-miR-30b-5p | miRNA | resistant | 1.0851 | 0.0043 | |
| N,n-diethylethanamine;6-[2-(4-hydroxy-3-nitrophenyl)ethylamino]-1h-benzimidazole-4,7-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.005 | 0.0302 | |
| N,n-dimethyl-4-[(e)-2-(1-methyl-2,5-diphenylpyrazol-1-ium-3-yl)ethenyl]aniline;trifluoromethanesulfonate | hsa-miR-30b-5p | miRNA | sensitive | -1.1606 | 0.0259 | |
| Nabor orange r | hsa-miR-30b-5p | miRNA | sensitive | -1.2908 | 0.0015 | |
| Naphth[2,3-d]oxazol-9-one, 2-methyl-4-(phenylimino)- | hsa-miR-30b-5p | miRNA | sensitive | -1.1487 | 0.02 | |
| Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- | hsa-miR-30b-5p | miRNA | sensitive | -1.0148 | 0.0495 | |
| Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- | hsa-miR-30b-5p | miRNA | resistant | 1.0583 | 0.0033 | |
| NSC617743 | hsa-miR-30b-5p | miRNA | sensitive | -1.0119 | 0.028 | |
| NSC618857 | hsa-miR-30b-5p | miRNA | resistant | 1.1598 | 0.0263 | |
| NSC621321 | hsa-miR-30b-5p | miRNA | sensitive | -1.0139 | 0.0297 | |
| NSC621335 | hsa-miR-30b-5p | miRNA | sensitive | -1.1835 | 0.0081 | |
| NSC625505 | hsa-miR-30b-5p | miRNA | sensitive | -1.0288 | 0.0187 | |
| NSC657270 | hsa-miR-30b-5p | miRNA | sensitive | -1.1557 | 0.0188 | |
| NSC695636 | hsa-miR-30b-5p | miRNA | sensitive | -1.1916 | 0.0005 | |
| NSC699071 | hsa-miR-30b-5p | miRNA | sensitive | -1.3131 | 0.0188 | |
| NSC762756 | hsa-miR-30b-5p | miRNA | resistant | 1.0838 | 0.0456 | |
| O-[5-(6-benzamidopurin-9-yl)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-3-yl] methylsulfanylmethanethioate | hsa-miR-30b-5p | miRNA | sensitive | -1.0542 | 0.0147 | |
| Pepleo | hsa-miR-30b-5p | miRNA | resistant | 1.0305 | 0.0012 | |
| Phenyl-[2-[2,3,4,5-tetrachloro-6-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]-3h-benzimidazol-5-yl]methanone | hsa-miR-30b-5p | miRNA | sensitive | -1.2053 | 0.0114 | |
| Piperidinium, 1,1-didodecyl-3-methyl-, bromide | hsa-miR-30b-5p | miRNA | sensitive | -1.1931 | 0.0016 | |
| Primaquine diphosphate | hsa-miR-30b-5p | miRNA | sensitive | -1.0659 | 0.0054 | |
| S-(dimethylarsino)-3-mercapto-1,2-propyl dinonanoate | hsa-miR-30b-5p | miRNA | sensitive | -1.0248 | 0.0275 | |
| Saponaceolide a | hsa-miR-30b-5p | miRNA | sensitive | -1.1689 | 0.0112 | |
| Spiro[3,6,7,8-tetrahydro-1h-cyclopenta[a]naphthalene-2,2'-3,6,7,8-tetrahydro-1h-cyclopenta[g]naphthalene]-5',9-dione | hsa-miR-30b-5p | miRNA | sensitive | -1.237 | 0.0063 | |
| Spiro[as-indacene-2(1h),2'(1'h)-[s]indacen]-1-one, 4'-acetyl-3,3',5',6,6',7,7',8-octahydro- | hsa-miR-30b-5p | miRNA | sensitive | -1.0523 | 0.0028 | |
| Tacacoside a2 | hsa-miR-30b-5p | miRNA | sensitive | -1.0151 | 0.0109 | |
| Tetra(isobutenyl)antimony bromide | hsa-miR-30b-5p | miRNA | sensitive | -1.3283 | 0.0049 | |
| Tetraoxo[?]dione | hsa-miR-30b-5p | miRNA | sensitive | -1.0048 | 0.001 | |
| Thioperoxydicarbonic diamide, tetramethyl- | hsa-miR-30b-5p | miRNA | sensitive | -1.1719 | 0.0029 | |
| Thiopyrimidine-ch3 | hsa-miR-30b-5p | miRNA | sensitive | -1.0054 | 0.0007 | |
| Thiosangivamycin | hsa-miR-30b-5p | miRNA | sensitive | -1.0487 | 0.0012 | |
| Vancide 26 | hsa-miR-30b-5p | miRNA | sensitive | -1.1129 | 0.0029 | |
| Ver a | hsa-miR-30b-5p | miRNA | sensitive | -1.0392 | 0.0083 | |
| Z198955462 | hsa-miR-30b-5p | miRNA | sensitive | -1.1116 | 0.0019 | |
| Z48861686 | hsa-miR-30b-5p | miRNA | sensitive | -1.4614 | 0.0001 | |
Network
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Drug-reponse_CCLE
No result!
Drug-target_Curated
| Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
|---|---|---|---|---|---|---|---|
| Decitabine + Trichostatin A | hsa-miR-30b-5p | miRNA | up-regulated | High | Pancreatic Cancer | Homo sapiens | |
| Decitabine | hsa-miR-30b-5p | miRNA | up-regulated | High | Pancreatic Cancer | Homo sapiens | |
| Trichostatin A | hsa-miR-30b-5p | miRNA | up-regulated | High | Pancreatic Cancer | Homo sapiens | |
| Estradiol | hsa-miR-30b-5p | miRNA | up-regulated | High | Breast Cancer | Homo sapiens | |
| Progesterone | hsa-miR-30b-5p | miRNA | down-regulated | High | Breast Cancer | Homo sapiens | |
| Trastuzumab | hsa-miR-30b-5p | miRNA | up-regulated | High | HER2-Positive Breast Cancer | Homo sapiens | |
| Trastuzumab | hsa-miR-30b-5p | miRNA | up-regulated | Low | HER2-Positive Breast Cancer | Homo sapiens | |
| Trastuzumab | hsa-miR-30b-5p | miRNA | up-regulated | High | Breast Cancer | Homo sapiens | |
| Trastuzumab | hsa-miR-30b-5p | miRNA | up-regulated | High | Breast Cancer | Homo sapiens | |
| 1,2,6-Tri-O-Galloyl-Beta-D-Glucopyranose | hsa-miR-30b-5p | miRNA | down-regulated | High | Hepatocellular Carcinoma | Homo sapiens | |
| Bicalutamide | hsa-miR-30b-5p | miRNA | down-regulated | High | Normal | Homo sapiens | |
| Stanolone | hsa-miR-30b-5p | miRNA | down-regulated | High | Prostate Cancer | Homo sapiens | |
| Calcitriol | hsa-miR-30b-5p | miRNA | down-regulated | High | Cervical Cancer | Homo sapiens | |
| Simvastatin + Ubiquinol | hsa-miR-30b-5p | miRNA | up-regulated | High | Hypercholesterolemia | Homo sapiens | |
| Resveratrol | hsa-miR-30b-5p | miRNA | down-regulated | High | Breast Cancer | Homo sapiens | |
| Andrographolide | hsa-miR-30b-5p | miRNA | up-regulated | Low | Hepatocellular Carcinoma | Homo sapiens | |
| Andrographolide | hsa-miR-30b-5p | miRNA | up-regulated | Low | Hepatocellular Carcinoma | Homo sapiens | |
| Brivaracetam | hsa-miR-30b-5p | miRNA | up-regulated | High | Glioblastoma | Homo sapiens | |
| Cisplatin | hsa-miR-30b-5p | miRNA | down-regulated | Low | Normal | Homo sapiens | |
| Yangzheng Sanjie Decoction | hsa-miR-30b-5p | miRNA | up-regulated | High | Gastric Cancer | Homo sapiens | |
| Matrine | hsa-miR-30b-5p | miRNA | down-regulated | Low | Acute T-Cell Lymphoblastic Leukemia | Homo sapiens | |
| Soft-Shelled Turtle Peptide | hsa-miR-30b-5p | miRNA | up-regulated | High | Gastric Cancer | Homo sapiens | |
| Shikonin | hsa-miR-30b-5p | miRNA | up-regulated | High | Endometrial Cancer | Homo sapiens | |
| Estradiol | hsa-miR-30b-5p | miRNA | up-regulated | High | Normal | Homo sapiens | |
| Estradiol | hsa-miR-30b-5p | miRNA | down-regulated | Low | Normal | Homo sapiens | |
| Norcantharidin | hsa-miR-30b-5p | miRNA | down-regulated | High | Giant Cell Tumor Of Bone | Homo sapiens | |
| Steviol | hsa-miR-30b-5p | miRNA | up-regulated | High | Colorectal Cancer | Homo sapiens | |
| Docetaxel + Cyclophosphamide | hsa-miR-30b-5p | miRNA | down-regulated | Low | Breast Cancer | Homo sapiens | |
| Kynurenine | hsa-miR-30b-5p | miRNA | down-regulated | Low | Breast Cancer | Homo sapiens | |
| Melatonin | hsa-miR-30b-5p | miRNA | up-regulated | High | Renal Cell Carcinoma | Homo sapiens | |
| Metformin + Gemigliptin | hsa-miR-30b-5p | miRNA | down-regulated | High | Type 2 Diabetes | Homo sapiens | |
| Metformin + Sulfonylurea(Glimepiride/Gliclazide) | hsa-miR-30b-5p | miRNA | down-regulated | High | Type 2 Diabetes | Homo sapiens | |
| HSCT-Allo | hsa-miR-30b-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
| Imatinib Mesylate | hsa-miR-30b-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Network
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Drug-target_GEO
| Compound | ncRNA | ncRNA Type | Pattern | log2FC | p-value | Detail |
|---|---|---|---|---|---|---|
| Sodium arsenite | hsa-miR-30b-5p | miRNA | down-regulated | -1.451 | NA | |
| Piperlongumine | hsa-miR-30b-5p | miRNA | up-regulated | 0.340 | 0.020 | |
| Grape seed proanthocyanidins | hsa-miR-30b-5p | miRNA | up-regulated | 0.387 | 0.009 | |
| Epigallocatechin Gallate | hsa-miR-30b-5p | miRNA | down-regulated | -3.907 | NA | |
| Epigallocatechin Gallate | hsa-miR-30b-5p | miRNA | down-regulated | -3.907 | NA | |
| Luteolin | hsa-miR-30b-5p | miRNA | up-regulated | 1.194 | NA | |
| Sodium dichloroacetate | hsa-miR-30b-5p | miRNA | down-regulated | -0.324 | 0.047 | |
| Sodium dichloroacetate | hsa-miR-30b-5p | miRNA | down-regulated | -0.513 | 0.003 | |
| Docetaxel | hsa-miR-30b-5p | miRNA | up-regulated | 1.254 | NA | |
| Benzo[a]pyrene | hsa-miR-30b-5p | miRNA | up-regulated | 0.289 | 0.001 | |
| SHU00238 | hsa-miR-30b-5p | miRNA | up-regulated | 0.758 | 1.87e-5 | |
| 3,8-Di-O-methylellagic acid 2-O-glucoside | hsa-miR-30b-5p | miRNA | up-regulated | 1.095 | 1.11e-24 | |
| Dorsomorphin | hsa-miR-30b-5p | miRNA | down-regulated | -0.699 | 0.002 | |
| Metformin | hsa-miR-30b-5p | miRNA | up-regulated | 0.832 | 5.01e-4 | |
| Cobalt chloride | hsa-miR-30b-5p | miRNA | up-regulated | 0.347 | 0.011 | |
| Methotrexate | hsa-miR-30b-5p | miRNA | up-regulated | 0.767 | 6.51e-4 | |
| Lidocaine | hsa-miR-30b-5p | miRNA | down-regulated | -2.172 | 3.93e-16 | |
| Dauricine | hsa-miR-30b-5p | miRNA | down-regulated | -2.381 | 0.002 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | up-regulated | 2.973 | 0.006 | |
| Calcitriol | hsa-miR-30b-5p | miRNA | up-regulated | 0.855 | 0.001 | |
| Calcitriol | hsa-miR-30b-5p | miRNA | down-regulated | -0.525 | 0.039 | |
| Calcitriol | hsa-miR-30b-5p | miRNA | up-regulated | 1.255 | 1.21e-5 | |
| Calcitriol | hsa-miR-30b-5p | miRNA | down-regulated | -0.680 | 0.009 | |
| Calcitriol | hsa-miR-30b-5p | miRNA | up-regulated | 0.775 | 0.003 | |
| Calcitriol | hsa-miR-30b-5p | miRNA | up-regulated | 0.740 | 0.005 | |
| Triamcinolone Acetonide | hsa-miR-30b-5p | miRNA | down-regulated | -0.844 | 0.013 | |
| Estradiol | hsa-miR-30b-5p | miRNA | down-regulated | -1.017 | 0.028 | |
| Estradiol | hsa-miR-30b-5p | miRNA | up-regulated | 0.972 | 0.035 | |
| Decitabine | hsa-miR-30b-5p | miRNA | down-regulated | -2.030 | NA | |
| Decitabine | hsa-miR-30b-5p | miRNA | up-regulated | 1.101 | NA | |
| Phorbol 12-myristate 13-acetate | hsa-miR-30b-5p | miRNA | up-regulated | 2.014 | NA | |
| Decitabine + 4-Phenylbutyric acid | hsa-miR-30b-5p | miRNA | up-regulated | 3.476 | NA | |
| Decitabine + 4-Phenylbutyric acid | hsa-miR-30b-5p | miRNA | up-regulated | 1.983 | NA | |
| Metformin | hsa-miR-30b-5p | miRNA | up-regulated | 1.337 | 0.023 | |
| Microcystin-LR | hsa-miR-30b-5p | miRNA | up-regulated | 4.060 | NA | |
| Budesonide/Fluticasone | hsa-miR-30b-5p | miRNA | up-regulated | 1.247 | NA | |
| Metformin | hsa-miR-30b-5p | miRNA | up-regulated | 0.355 | 0.011 | |
| Triptolide | hsa-miR-30b-5p | miRNA | down-regulated | -0.780 | 0.030 | |
| KU55933 | hsa-miR-30b-5p | miRNA | down-regulated | -1.238 | NA | |
| Cyclosporin A | hsa-miR-30b-5p | miRNA | down-regulated | -0.967 | 0.039 | |
| Triptolide | hsa-miR-30b-5p | miRNA | down-regulated | -0.208 | 0.005 | |
| Cocaine | hsa-miR-30b-5p | miRNA | down-regulated | -1.676 | NA | |
| Cocaine | hsa-miR-30b-5p | miRNA | down-regulated | -1.717 | NA | |
| Dexamethasone | hsa-miR-30b-5p | miRNA | up-regulated | 1.101 | NA | |
| Cisplatin | hsa-miR-30b-5p | miRNA | up-regulated | 0.535 | 0.006 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | up-regulated | 0.413 | 0.031 | |
| Cisplatin | hsa-miR-30b-5p | miRNA | up-regulated | 0.451 | 0.019 | |
| Berberine chloride | hsa-miR-30b-5p | miRNA | up-regulated | 1.634 | NA | |
| Antrodia cinnamomea fruiting body extract | hsa-miR-30b-5p | miRNA | down-regulated | -1.607 | NA | |
| Antrodia cinnamomea fruiting body extract | hsa-miR-30b-5p | miRNA | down-regulated | -2.108 | NA | |
| Antrodia cinnamomea fruiting body extract | hsa-miR-30b-5p | miRNA | down-regulated | -2.617 | NA | |
| Antrodia cinnamomea fruiting body extract | hsa-miR-30b-5p | miRNA | down-regulated | -2.220 | NA | |
| RPI-1 | hsa-miR-30b-5p | miRNA | up-regulated | 0.856 | 0.004 | |
| 5-azacytidine | hsa-miR-30b-5p | miRNA | down-regulated | -1.309 | NA | |
| 5-azacytidine | hsa-miR-30b-5p | miRNA | down-regulated | -1.076 | NA | |
| Decitabine + Trichostatin A | hsa-miR-30b-5p | miRNA | down-regulated | -0.674 | 0.008 | |
| Decitabine + Trichostatin A | hsa-miR-30b-5p | miRNA | down-regulated | -0.732 | 0.005 | |
| Vorinostat | hsa-miR-30b-5p | miRNA | up-regulated | 1.292 | NA | |
| Vorinostat | hsa-miR-30b-5p | miRNA | up-regulated | 2.033 | NA | |
| Panobinostat | hsa-miR-30b-5p | miRNA | up-regulated | 1.220 | NA | |
| Panobinostat | hsa-miR-30b-5p | miRNA | up-regulated | 1.716 | NA | |
| Ceritinib+Panobinostat | hsa-miR-30b-5p | miRNA | up-regulated | 0.567 | 4.42e-5 | |
| Cyclosporine A | hsa-miR-30b-5p | miRNA | down-regulated | -0.482 | 0.043 | |
| Cyclosporine A | hsa-miR-30b-5p | miRNA | down-regulated | -0.580 | 0.032 | |
| Estradiol | hsa-miR-30b-5p | miRNA | up-regulated | 1.857 | NA | |
| Ibrutinib | hsa-miR-30b-5p | miRNA | up-regulated | 0.403 | 0.040 | |
| UNC1999 | hsa-miR-30b-5p | miRNA | down-regulated | -0.240 | 0.024 | |
Network
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Drug-target_CMap